Related Experiment Video
Updated: Jun 1, 2026
08:57
Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis
A Sureshbabu1, E Tonner, G J Allan
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, SIPBS Building, 161 Cathedral Street, Glasgow G4 0RE, UK.
Pulmonary Medicine
|June 4, 2011
Summary
Idiopathic pulmonary fibrosis (IPF) lacks treatments. While TGF-β1 worsens fibrosis, IGFBP-5 may promote epithelial repair, offering a potential therapeutic target for antifibrotic therapies.
Area of Science:
- Fibrosis research
- Cellular biology
- Tissue repair mechanisms
Background:
- Scarring (fibrosis) affects major organs due to impaired epithelial self-renewal.
- Idiopathic pulmonary fibrosis (IPF) currently has no effective therapies.
- Transforming growth factor-beta 1 (TGF-β1) is a key profibrotic factor, and inhibitors are under investigation.
Purpose of the Study:
- To investigate the distinct roles of TGF-β1 and Insulin-like Growth Factor Binding Protein 5 (IGFBP-5) in epithelial cells during fibrosis.
- To evaluate IGFBP-5 as a potential therapeutic target for antifibrotic treatments.
Main Methods:
- Comparative analysis of TGF-β1 and IGFBP-5 effects on epithelial cells.
- Assessment of cellular responses including proliferation, death, and matrix interaction.
Main Results:
- Both TGF-β1 and IGFBP-5 activate mesenchymal cells, increasing collagen and fibronectin.
- TGF-β1 induces epithelial cell death and/or epithelial-mesenchymal transition (EMT), disrupting tissue architecture.
- IGFBP-5 promotes epithelial cell spreading, enhances laminin secretion, and improves survival in nutrient-poor conditions.
Conclusions:
- IGFBP-5 exhibits distinct, potentially reparative effects on epithelial cells compared to TGF-β1.
- IGFBP-5 may enhance tissue repair in fibrotic conditions.
- IGFBP-5 represents a promising therapeutic target for developing novel antifibrotic strategies.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...